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Introduction
Eukaryotic mRNAs are degraded by two alternative pathways, 
both of which are initiated by a gradual shortening of the 
poly(A) tail by deadenylation. In one, the 3 to 5 decay path-
way, the poly(A) tail is first removed, and then the exosome and 
cofactors digest the mRNA exonucleolytically from the 3 end 
(Houseley et al., 2006). In the other, the 5 to 3 decay pathway, 
deadenylation is followed by the removal of the 5 cap structure 
by the decapping enzyme DCP2; decapped mRNA is then   
susceptible to 5 to 3 exonucleolytic degradation by XRN1 
(Bail and Kiledjian, 2006; Simon et al., 2006).
The decapping enzyme DCP2 requires additional proteins 
for full activity and/or stability (Bail and Kiledjian, 2006; Simon 
et al., 2006). Proteins that enhance decapping in Saccharomyces 
cerevisiae include DCP1, EDC1–3 (enhancer of decapping 1, 2, 
and 3), the heptameric LSm1–7 complex, Dhh1 (DExH/D-box 
RNA helicase 1; Me31B in Drosophila melanogaster), and Pat1 
(HPat in D. melanogaster). With the exception of EDC1 and -2, 
these proteins are conserved, yet most are not functionally char-
acterized in multicellular eukaryotes.
In S. cerevisiae, Pat1 interacts with the Lsm1–7 com-
plex and Dhh1 (Bonnerot et al., 2000; Bouveret et al., 2000; 
Fromont-Racine et al., 2000; Tharun et al., 2000; Coller et al., 
2001; Tharun and Parker, 2001; Fischer and Weis, 2002). The 
Pat1–LSm1–7 complex preferentially binds to the 3 ends   
of  oligoadenylated  mRNAs  that  have  undergone  deadenyl-
ation, thereby protecting them from 3 trimming and further 
degradation (He and Parker, 2001; Tharun and Parker, 2001;   
Chowdhury et al., 2007; Chowdhury and Tharun, 2008, 2009). 
This complex then activates decapping, most likely by recruit-
ing additional decapping activators and the decapping enzyme 
DCP2 (Hatfield et al., 1996; Bouveret et al., 2000; He and 
Parker, 2001; Chowdhury et al., 2007; Decker et al., 2007; 
Chowdhury and Tharun, 2008, 2009; Pilkington and Parker, 
2008; Tharun, 2009). Pat1 also associates with DCP1, DCP2, 
and EDC3 in yeast, which is consistent with a role in decapping 
(Fromont-Racine et al., 2000; Tharun et al., 2000; Tharun and 
Parker, 2001; Pilkington and Parker, 2008). Additionally, Pat1 
and the LSm1–7 complex copurify with Xrn1 (Bouveret et al., 
2000), suggesting a possible role for Pat in coupling decap-
ping to 5 to 3 mRNA degradation.
Like many components of the 5 to 3 mRNA decay 
pathway, Pat1 localizes to P bodies and, moreover, is required 
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Results
HPat coimmunoprecipitates Me31B, 
DCP2, and the LSm1–7 complex
To systematically investigate the network of interactions between 
HPat and decapping activators in metazoa, we coexpressed HA-, 
V5-, or GFP-tagged versions of these proteins in D. melanogas-
ter S2 cells and used anti-HA antibodies to coimmunoprecipi-
tate V5- or GFP-tagged proteins from cell lysates. We used this 
method to detect interactions with DCP1, DCP2, EDC3, EDC4, 
Me31B, Tral (trailer hitch), XRN1, and components of the 
LSm1–7 complex.
HPat  coimmunoprecipitated  with  Me31B  but  not  with 
DCP1, EDC3, or Tral (Fig. 1 A, lanes 7–10). Both EDC3 and 
Tral interact directly with Me31B (Tritschler et al., 2009), sug-
gesting that the interaction of HPat with Me31B mutually ex-
cludes an interaction with Me31B–EDC3 or Me31B–Tral (see 
Figs. 3 and 4). When coexpressed in Escherichia coli, recombi-
nant protein fragments of HPat and Me31B interact, showing 
the proteins bind each other directly (unpublished data).
In  yeast,  Pat1  associates  with  the  LSm1–7  complex   
(Bonnerot et al., 2000; Bouveret et al., 2000; Fromont-Racine 
et al., 2000; Tharun et al., 2000; Tharun and Parker, 2001). 
Accordingly,  we  observed  that  HPat  coimmunoprecipitated 
LSm1, -3, and -7 (Fig. 1 B). HPat interaction with LSm1 was 
insensitive to RNase A treatment (Fig. S1 A), suggesting that 
it is not mediated by RNA. LSm1 and -7 also coimmunopre-
cipitated with Me31B but not with any of the other proteins 
tested (Fig. 1 C; Tritschler et al., 2007, 2008). Finally, we observed 
that HPat coimmunoprecipitated DCP2 in an RNA-independent 
manner but not XRN1 or EDC4 (Fig. 1 D; Fig. S1, B and C; and 
not depicted). Thus, in addition to the interactions with Me31B 
and the LSm1–7 ring, which are conserved in S. cerevisiae, 
we detected an RNase A–insensitive interaction between HPat 
and DCP2. In contrast to our findings in this study, this inter-
action is sensitive to RNase A treatment in yeast (Tharun and 
Parker, 2001).
Me31B binds to the conserved N-terminal 
sequence of HPat
The interaction of HPat with Me31B is conserved in S. cerevisiae 
(Coller et al., 2001; Fischer and Weis, 2002). Despite conserva-
tion, the protein domains involved in this interaction were not 
defined. To identify them, we performed co-IP assays using   
different HPat and Me31B deletion mutants. Pat1 orthologues 
are characterized by a conserved N-terminal sequence of 50 
residues, a proline-rich region, a Mid domain, and a C-terminal 
domain termed Pat-C (Fig. 2, A and B). The boundary between 
the Mid domain and Pat-C was chosen on the basis of sequence 
alignments between Pat1 orthologues from various species.
We  observed  that  Me31B  interacted  only  with  an   
N-terminal fragment of HPat (residues 1–499) but not with a con-
struct comprising the Mid domain and Pat-C (Fig. 2 C, lanes   
8 and 9). The N-terminal fragment contains the conserved   
N-terminal sequence (residues 1–56; Fig. 2 B) and the proline-rich 
region (13.6%), which is particularly long in the D. melanogaster  
protein and also rich in glutamine residues (16%; Fig. 2 A,   
for P-body integrity (Pilkington and Parker, 2008). A fraction   
of Pat1 is also found in polysomes (Bonnerot et al., 2000; 
Wyers  et  al.,  2000),  suggesting  that  it  associates  with  ac-
tively translated mRNAs and may commit them to degrada-
tion in response to a triggering signal (Bonnerot et al., 2000).   
Intriguingly, Pat1 was reported to play dual roles in transla-
tion: it stimulates translation initiation (Wyers et al., 2000) 
but is also required for general translational repression dur-
ing glucose deprivation (Coller and Parker, 2005). Further-
more, Pat1 overexpression can repress translation and cause 
mRNAs to accumulate in P bodies (Coller and Parker, 2005). 
These and additional studies suggest that Pat1 is a key regula-
tor in the transition of mRNAs from a translationally active 
state associated with polysomes to a ribosome-free transla-
tionally repressed state that commits the mRNA to degrada-
tion (Coller and Parker, 2005; Pilkington and Parker, 2008). 
In this repressed state, mRNAs may aggregate into P bodies 
(Coller and Parker, 2005).
Pat1 is conserved in eukaryotes, and Pat1 orthologues in 
D. melanogaster and human cells (HPat and PatL1, respec-
tively) localize to P bodies (Eulalio et al., 2007a; Scheller et al., 
2007). The role of metazoan Pat1 orthologues in decapping is 
also conserved, as suggested by the observation that codeple-
tion of HPat and Me31B strongly inhibits decapping triggered 
by microRNAs or by tethered GW182 in D. melanogaster cells 
(Eulalio et al., 2007c). Nonetheless, the interactions of Pat1   
orthologues with additional decapping activators and the role   
of Pat1 orthologues in decapping remain largely unknown in 
multicellular eukaryotes.
Pat1 proteins are characterized by a conserved N-terminal 
sequence, a proline-rich region, a middle (Mid) domain, and   
a C-terminal domain (termed Pat-C). A study in S. cerevisiae 
showed that the Pat1 Mid domain interacts with the LSm1–7 
ring  and  is  essential  for  decapping  in  vivo  (Pilkington  and 
Parker, 2008). Sequences located N- or C-terminally to the Mid 
domain stimulate but are not required for decapping. Further-
more, Pat-C is required for Pat1 to localize to P bodies and con-
fers the interaction with DCP1, EDC3, and RNA (Pilkington 
and Parker, 2008).
In this study, we analyzed HPat interactions and function 
in D. melanogaster using coimmunoprecipitation (co-IP) and 
complementation assays. In addition to the interaction between 
HPat and Me31B, DCP2 or the LSm1–7 complex, which are 
conserved in yeast, our study revealed that HPat interacts with 
the CCR4–NOT deadenylase complex. These findings suggest 
that HPat plays a role in coupling decapping to deadenylation. 
Accordingly, we observed that HPat promotes deadenylation 
and decapping of mRNAs in tethering assays. Unexpectedly, 
these activities are mediated by a proline-rich region, which 
we show is also required for P-body integrity. However, in 
contrast to results in yeast, we show that in addition to the Mid 
domain, both the proline-rich region and Pat-C are required to 
restore decapping in cells depleted of endogenous HPat. Our 
findings reveal that yeast and D. melanogaster differ signifi-
cantly as to which HPat domains are required for decapping, 
highlighting the importance of characterizing decapping com-
plexes in metazoa.291 HPat links deadenylation and decapping • Haas et al.
fused to GFP could be coimmunoprecipitated from cell lysates 
using anti-HA antibodies. We observed that HA-Me31B coim-
munoprecipitated GFP-HPat and -EDC3, showing that Me31B 
does indeed interact with both proteins (Fig. 3 C, lanes 8–10). 
In contrast, HA-HPat coimmunoprecipitated GFP-Me31B but 
not GFP-EDC3 (Fig. 3 D, lanes 8–10), whereas HA-EDC3 co-
immunoprecipitated GFP-Me31B but not GFP-HPat (Fig. 3 E, 
lanes 8–10). Similar results were obtained when EDC3 was 
substituted by Tral in the co-IP assays (Fig. S2), suggesting that 
Me31B associates with HPat, Tral, and EDC3 to form distinct 
protein complexes.
EDC3 competes with HPat for binding  
to Me31B
The crystal structure of RCK (human Me31B orthologue) in 
complex with the FDF motif of EDC3 revealed surface residues 
on RCK (or Me31B) that are critical for the interaction with 
EDC3 and Tral (Tritschler et al., 2009). To determine whether 
HPat competes with EDC3 and Tral for this same binding   
surface, we tested whether an Me31B mutant that does not 
interact with EDC3 (or Tral) could still bind HPat. Specifically, 
we took advantage of an Me31B (Mut1) mutated at four surface 
residues  involved  in  the  interaction  with  the  FDF  motifs  of 
EDC3 and Tral. We also tested an Me31B mutant (Mut2) that 
interacts with Tral but not with EDC3 (Tritschler et al., 2009). 
In IP assays, the two Me31B mutants interacted with HPat   
(Fig. 4 A, lanes 8–10), whereas Me31B-Mut1 did not interact 
with EDC3 as expected (Fig. 4 A, lane 12).
P-rich region). Because the interaction of HPat with Me31B is 
conserved, we hypothesized it could be mediated by the con-
served N-terminal sequence. Indeed, we observed that an HPat 
protein lacking the N-terminal sequence did not interact with 
Me31B (Fig. 2 C, lane 10). Conversely, a protein fragment com-
prising only the conserved N-terminal sequence was sufficient 
for the interaction with Me31B (Fig. 2 D, lane 9). Thus, the 
conserved N-terminal sequence represents the Me31B-binding 
site in HPat.
HPat, EDC3, or Tral assembles with 
Me31B into distinct protein complexes
Me31B is a DEAD-box helicase and, like all members of this 
protein family, consists of two RecA-like domains (Fig. 3 A). 
Previously, we showed that the C-terminal RecA-like domain 
interacts in a mutually exclusive manner with the FDF motifs of 
EDC3 and Tral (Tritschler et al., 2008, 2009). Surprisingly, in 
this study, we could also detect an interaction between the 
Me31B C-terminal RecA-like domain and full-length HPat 
(Fig.  3  B,  lane  8)  or  with  the  HPat  conserved  N-terminal   
sequence (Fig. 2 D, lane 12). However, HPat did not interact 
with EDC3 or Tral (Fig. 1 A), suggesting that HPat, EDC3, and 
Tral may form mutually exclusive interactions with Me31B.
To investigate this possibility further, we cotransfected S2 
cells with mixtures of plasmids encoding three proteins: EDC3 
(or Tral), HPat, and Me31B. We used three different mixtures, 
each containing a plasmid expressing one HA-tagged and two 
GFP-tagged proteins. We then assayed whether the proteins 
Figure 1.  HPat coimmunoprecipitates DCP2, 
Me31B, and the LSm1–7 complex. (A–D) GFP-, 
V5-,  and  HA-tagged  proteins  were  coex-
pressed in S2 cells as indicated. Cell lysates 
were immunoprecipitated using a monoclonal 
anti-HA antibody. HA-tagged versions of GST 
or MBP served as negative controls. Inputs 
(1%)  and  immunoprecipitates  (10%)  were 
analyzed by Western blotting. In D, 30% of 
the IP fraction was loaded. Asterisks indicate 
cross-reactivity of the primary antibodies with 
an endogenous protein (input panels) or of the 
secondary antibody with the immunoglobulin 
heavy chain (IP panels). Molecular mass is   
indicated in kilodaltons.JCB • VOLUME 189 • NUMBER 2 • 2010   292
peptide also competes with Tral for binding to Me31B (Tritschler 
et al., 2009), we conclude that HPat, EDC3, and Tral interact 
with Me31B in a mutually exclusive manner.
The Mid domain of HPat confers 
interaction with the LSm1–7 complex
Next, we tested which HPat domains can interact with LSm1 and 
DCP2. We observed that a fragment of HPat containing the Mid 
domain plus Pat-C (residues 500–968) was necessary and suffi-
cient to interact with both LSm1 and DCP2 (Fig. 5, A–D). When 
the Mid domain and Pat-C were tested individually, we observed 
that both LSm1 and DCP2 interacted with the Mid domain but 
not with Pat-C (Fig. 5, B and D). However, the interaction of 
DCP2 with the Mid domain was less efficient than with the frag-
ment also containing Pat-C, suggesting that Pat-C contributes to 
DCP2 binding. These results, together with the observation that 
DCP2 does not interact with LSm1 (Fig. S1 D), suggest that DCP2 
binds HPat independently of the LSm1–7 ring.
Our results indicate that HPat binds to Me31B via surface 
residues different than those contacting EDC3 (or Tral); yet, the 
Me31B interaction with HPat and EDC3 (or Tral) appears to   
be mutually exclusive, suggesting that the binding surfaces   
partially overlap. Alternatively, EDC3 (or Tral) may interfere 
with HPat binding as the result of steric hindrance.
To further investigate whether EDC3, Tral, and HPat form 
mutually exclusive interactions with Me31B, we performed 
competition assays. In these assays, we tested whether a peptide 
containing the Me31B-binding domain of EDC3 (i.e., the FDF 
motif) competed with HPat for binding to Me31B when added 
to cell lysates before IP. Indeed, the peptide did interfere with 
HPat binding to Me31B, as expected for a mutually exclusive 
interaction (Fig. 4 B, lanes 9 and 10). As a control, we tested the 
corresponding peptide carrying alanine substitutions of the 
phenylalanine residues in the EDC3-FDF motif (ADA peptide); 
this peptide no longer binds Me31B and had no effect (Fig. 4 B, 
lanes 11 and 12; Tritschler et al., 2009). Because the EDC3-FDF 
Figure 2.  The N-terminal conserved sequence mediates HPat interaction with Me31B. (A) Domain organization of HPat. HPat proteins contain a conserved 
N-terminal (N-ter) sequence, a glutamine/proline-rich region (P-rich), a Mid domain, and Pat-C. Numbers above the protein outline represent amino acid 
positions at fragment boundaries for the D. melanogaster protein. S. cerevisiae Pat1 is shown for comparison. (B) Sequence alignment of the N-terminal 
conserved sequence of Pat1 orthologues from Homo sapiens (Hs), Danio rerio (Dr), D. melanogaster (Dm), Caenorhabditis elegans (Ce), and S. cerevi-
siae (Sc). Asterisks indicate invariant residues. Hydrophobic, polar, and acidic residues are shaded in blue, green and magenta, respectively. Glycines 
are shaded orange. Unconserved acidic and basic residues are shaded light magenta and yellow, respectively. (C and D) Interaction between full-length   
GFP-HPat or HPat fragments with full-length Me31B or its C-terminal RecA-like domain. Cell lysates were immunoprecipitated and analyzed as described 
in Fig. 1. Molecular mass is indicated in kilodaltons.293 HPat links deadenylation and decapping • Haas et al.
which interacts with Me31B, spread throughout the cell (Fig. 6 D).   
Moreover, when overexpressed, this protein fusion affected the 
integrity of endogenous P bodies, significantly reducing them 
in number and size (Fig. 6 D). In contrast, the proline-rich   
region accumulated in P bodies in 47% of the cells (Fig. 6 E), 
suggesting that the proline-rich region is sufficient for P-body 
localization. In line with this interpretation, we found that an 
HPat  mutant  lacking  the  proline-rich  region  was  evenly  dis-
tributed throughout the cell (Fig. 6 F). Furthermore, the over-
expression of this mutant affected the integrity of endogenous 
P bodies in a dominant-negative manner. We conclude that the 
proline-rich region of HPat plays a critical role in maintaining   
P-body integrity and promoting HPat accumulation in P bodies.
HPat promotes degradation  
of bound mRNAs
To better understand the function of HPat in decapping, we inves-
tigated whether binding of HPat to an mRNA was sufficient to 
promote degradation. To this end, we made use of the tethering   
The proline-rich region is required for  
P-body localization
HPat localizes to P bodies both in S. cerevisiae and in metazoa 
and is required for P-body integrity (Eulalio et al., 2007a,b; 
Parker and Sheth, 2007). This localization does not appear to be 
affected by a GFP tag (Fig. 6 A). Therefore, we sought to define 
which interactions are critical for HPat accumulation in P bod-
ies by examining where HPat fragments localize. A fragment 
of HPat comprising the N-terminal conserved sequence and the 
proline-rich region localized to P bodies in 37% of the cell 
population (Fig. 6 B), whereas a fragment comprising the Mid 
domain and Pat-C, which interacts with DCP2 and the LSm1–7 
ring, dispersed throughout the cytoplasm (Fig. 6 C). This sug-
gests that the N-terminal fragment retains the ability to localize 
to P bodies, although not as efficiently as full-length HPat, which 
localized to P bodies in 87% of the cell population (Fig. 6 A).
We next investigated whether the N-terminal conserved 
sequence or the proline-rich region were sufficient for P-body 
localization. A GFP fusion of the HPat N-terminal sequence, 
Figure  3.  HPat  interacts  with  the  C-terminal 
RecA-like  domain  of  Me31B.  (A)  Me31B 
consists  of  two  RecA-like  domains.  Numbers 
above  the  protein  outline  represent  amino 
acid positions at fragment boundaries for the 
D. melanogaster protein. N-ter, N-terminal; 
C-ter,  C-terminal.  (B)  HA-tagged  Me31B  or 
the indicated Me31B protein fragments were 
coexpressed in S2 cells with GFP-HPat. Cell 
lysates were immunoprecipitated and analyzed 
as described in Fig. 1. (C–E) S2 cells were   
cotransfected with mixtures of three plasmids. 
In  C,  the  plasmids  encoded  HA-Me31B,   
GFP-HPat, and GFP-EDC3; in D, the plasmids en-
coded HA-HPat, GFP-Me31B, and GFP-EDC3; 
in  E,  the  mixture  consisted  of  HA-EDC3,   
GFP-Me31B,  and  GFP-HPat.  In  all  panels, 
HA-GST  served  as  a  negative  control.  Cell   
lysates  were  immunoprecipitated  and  ana-
lyzed as described in Fig. 1. Arrows indicate 
EDC3 or HPat protein degradation fragments. 
Asterisks  indicate  cross-reactivity  of  the  pri-
mary antibodies with an endogenous protein 
(input panels) or of the secondary antibody 
with  the  immunoglobulin  heavy  chain  (IP 
panels). (B–E) Molecular mass is indicated 
in kilodaltons.JCB • VOLUME 189 • NUMBER 2 • 2010   294
Together, these results indicate that HPat directs bound mRNAs 
to degradation.
The proline-rich region is required for HPat 
to degrade bound mRNAs
We next performed tethering assays using the aforementioned 
HPat deletion mutants. We observed that deleting the con-
served N-terminal sequence, which interacts with Me31B, re-
duced HPat activity in the tethering assay (Fig. 7 A, N-ter). In   
contrast, HPat mutants lacking either the Mid domain or Pat-C 
individually or simultaneously (Fig. 7, A and B, N-ter+P-rich) 
were fully active.
Unexpectedly, deleting the proline-rich region abolished 
HPat activity (Fig. 7, A and B, P-rich). Conversely, the proline-
rich region alone was more active than full-length HPat (Fig. 7, 
A and B, P-rich). All proteins were expressed at comparable 
levels (Fig. 7 C). We conclude that the proline-rich region   
is  both  necessary  and  sufficient  to  trigger  degradation  of 
bound mRNAs.
HPat triggers deadenylation and decapping
Given the role of HPat and orthologues in mRNA decapping, 
we  next  tested  whether  HPat-mediated  mRNA  degradation   
required the activity of decapping activators. To this end, we 
performed the tethering assay in cells codepleted of two de-
capping activators, DCP1 and EDC4. In such cells, decapping   
was efficiently inhibited, blocking mRNA degradation caused 
by tethered GW182 (Fig. 7, D and E [lane 2 vs. lane 1]). The   
accumulated transcripts were shorter, which is consistent with 
the  observation  that  GW182  triggers  mRNA  deadenylation 
(Behm-Ansmant et al., 2006). We confirmed that these tran-
scripts  lack  a  poly(A)  tail  by  oligo  (dT)–targeted  RNase  H 
cleavage (Fig. 7 F). Specifically, in cells expressing N-HA–
AGO1-F2V2, both the F-Luc reporter and the endogenous rp49 
mRNA (encoding ribosomal protein L32) migrated faster after 
oligo (dT)–directed RNase H cleavage had removed the poly(A) 
tail (Fig. 7 F, lane 2 vs. lane 1). In contrast, in cells expressing 
N-HA–GW182, RNase H treatment did not affect F-Luc   
reporter mobility, indicating that it was already deadenylated 
(Fig. 7 F, lane 4 vs. lane 3).
Codepletion of DCP1 and EDC4 also prevented HPat- 
mediated degradation of the reporter, which accumulated both 
in the poly- and deadenylated form (Fig. 7, E [lane 3] and F 
[lane 6 vs. lane 5]). The polyadenylated form corresponded 
to the fraction of the mRNA that was not degraded by HPat   
(Fig. 7 B, lane 3). The accumulation of the deadenylated form 
indicates that HPat promotes deadenylation. This finding might 
explain why luciferase activity is not restored despite restora-
tion of mRNA levels (Fig. 7 D) because deadenylated transcripts 
are translated less efficiently. Similar results were obtained for 
all HPat fragments containing the proline-rich region (Fig. 7,   
D and E).
We could not analyze the effect of codepleting DCP1 and 
EDC4 in cells expressing two HPat fragments (N-ter+P-rich 
and P-rich) because overexpressing these fragments had cyto-
toxic effects (i.e., low recovery of transfected cells). This was 
not observed in control cells, suggesting that in the background 
assay previously described (Gehring et al., 2005). This assay 
involves the expression of N fusion proteins that bind with 
high affinity to five BoxB hairpins (5BoxB) in the 3 untrans-
lated region of a firefly luciferase (F-Luc) reporter mRNA   
(F-Luc–5BoxB reporter).
S2 cells were transiently transfected with the F-Luc–5BoxB 
reporter, a plasmid expressing HPat fused to the N-HA pep-
tide, and a plasmid encoding Renilla luciferase (R-Luc). As   
negative control, we used an inactive mutant of the Argonaute-1   
protein (AGO1-F2V2) because this protein is comparable in 
size with HPat. Relative to cells expressing the AGO1-F2V2 
mutant, tethered N-HA–HPat reduced F-Luc activity 2.5-fold 
(Fig.  7 A). A  stronger  inhibitory  effect  was  observed  for 
GW182, which served as a positive control (Fig. 7 A; Behm-
Ansmant et al., 2006).
To determine whether HPat inhibits F-Luc activity by re-
pressing translation directly or indirectly by reducing mRNA 
levels, we analyzed by Northern blot the steady-state levels of 
the F-Luc–5BoxB mRNA. We found that N-HA–HPat par-
tially reduced reporter mRNA (Fig. 7, A and B [lane 3]) at 
a level that fully accounted for the decrease of F-Luc activity 
(Fig. 7 A, black vs. gray bars). HPat did not affect the expression 
of an F-Luc reporter lacking the BoxB elements (Fig. S1 E).   
Figure 4.  Me31B establishes mutually exclusive interactions with HPat, 
EDC3, and Tral. (A) HA-tagged Me31B or the indicated Me31B mutants 
were coexpressed in S2 cells with GFP-HPat or -EDC3. Cell lysates were 
immunoprecipitated and analyzed as described in Fig. 1. Me31B mutants 
carry  alanine  substitutions  of  the  following  residues:  Gln281,  His284, 
Tyr288, and Lys292 (Mut1) or Phe405, His408, Glu411, and Lys412 
(Mut2). (B) HA-MBP or -Me31B was coexpressed with GFP-HPat in S2 
cells. Cell lysates were immunoprecipitated using a monoclonal anti-HA 
antibody. In lanes 3–6 and 9–12, increasing amounts (5 and 20 µg) of   
purified recombinant EDC3-FDF peptide or of the corresponding ADA 
mutant were added to the cell lysates before IP as indicated. (A and B) 
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levels of F-Luc–5BoxB mRNA over time (as compared with the 
long-lived rp49 mRNA, which has a half-life >8 h). In cells ex-
pressing the AGO1-F2V2 mutant, the half-life of F-Luc–5BoxB 
mRNA was 2 h, whereas in cells expressing N-HPat or the 
proline-rich region, the half-life of this mRNA was 40 min or 
10 min, respectively (Fig. 7 I). Importantly, in cells expressing 
HPat or the proline-rich region, the F-Luc–5BoxB transcripts 
accumulating  15–90  min  after  adding  actinomycin  D  were 
deadenylated (Fig. 7 I). These results further demonstrate that 
HPat-mediated decay is initiated by deadenylation. Collectively, 
our results indicate that HPat triggers deadenylation followed 
by decapping of bound mRNAs and that these activities reside 
in the proline-rich region.
of  the  double  DCP1–EDC4  knockdown,  these  protein  frag-
ments are toxic.
To further demonstrate that HPat triggers deadenylation 
followed by decapping, we performed two independent ex-
periments. First, we examined the F-Luc–5BoxB mRNA in 
cells expressing a dominant-negative mutant of DCP2 that 
strongly  inhibits  decapping  in  S2  cells  partially  depleted   
of endogenous DCP2. Again, in the presence of GW182 or 
HPat,  the  reporter  accumulated  in  the  deadenylated  form,   
co-migrating with an F-Luc–5BoxB transcript lacking the 
poly(A) tail (Fig. 7 H).
In the second experiment, we exposed transfected cells to 
actinomycin D to inhibit transcription and then analyzed the 
Figure 5.  The Mid domain and Pat-C interact with DCP2 and the LSm1–7 complex. (A–D) Interaction between full-length HPat or HPat fragments with GFP-
LSm1 or DCP2-V5. Protein interactions were analyzed as described in Fig. 1. Asterisks indicate cross-reactivity of the anti-HA antibody with an endogenous 
protein (input panels) or of the V5 antibody with the immunoglobulin heavy chain (IP panels). Note that in C, a degradation product arising from full-length 
HPat, an HPat fragment containing the N-terminal (N-ter) and proline-rich (P-rich) regions (in lanes 1–4), and the fragment containing the Mid domain and 
Pat-C (lanes 5 and 6) have a similar mobility (arrow). Molecular mass is indicated in kilodaltons.JCB • VOLUME 189 • NUMBER 2 • 2010   296
that  HPat  coimmunoprecipitated  components  of  the  CCR4–
NOT complex (including POP2, CCR4, NOT2, NOT3/5, and 
NOT4) in an RNA-independent manner (Fig. 8 A). These 
results suggest that HPat acts as an adaptor molecule, bridg-
ing the interaction between the deadenylation and decapping   
machineries. However, it is important to note that HPat is not   
required  for  deadenylation  per  se  because  depleting  HPat 
causes deadenylated mRNAs to accumulate. Thus, in the ab-
sence of HPat, only decapping but not deadenylation is inhib-
ited (Fig. 9; Eulalio et al., 2007c), which is in agreement with 
the results reported previously in yeast (Bouveret et al., 2000; 
He and Parker, 2001; Tharun and Parker, 2001).
To define the domains of HPat required for the interaction 
with CCR4–NOT deadenylase complex components, we per-
formed co-IP assays with the aforementioned protein fragments. 
We observed that the Mid domain was both necessary and suffi-
cient for HPat to interact with CCR4 (Fig. 8, B and C).
The Mid domain and Pat-C are required for 
decapping in vivo
The tethering assay allows functional domains to be identified 
once HPat is artificially tethered to an mRNA, but additional 
domains may also be essential for HPat function because they 
mediate target binding. To further investigate the requirement 
for HPat domains in decapping, we established a complemen-
tation assay in which endogenous HPat was depleted using a 
double-stranded RNA (dsRNA) targeting HPat ORF. HPat frag-
ments were then tested for their ability to restore decapping in 
HPat-depleted cells. Transcripts encoding the recombinant pro-
teins were made resistant to the dsRNA by introducing muta-
tions that disrupt base pair interactions with the dsRNA without 
altering the protein sequence.
To monitor decapping, we used the F-Luc–5BoxB re-
porter tethered to GW182. The GW182 triggers deadenylation 
of  the  F-Luc–5BoxB  reporter,  which  is  then  decapped,  and 
subsequently, the mRNA body is digested exonucleolytically   
(Fig. 7; Behm-Ansmant et al., 2006). Inhibiting decapping 
prevents mRNA degradation by GW182, and so deadenylated 
decay intermediates accumulate (Fig. 7 E, lane 2 vs. lane 1). 
Therefore, the accumulation of the deadenylated F-Luc–5BoxB 
mRNA reflects a block in decapping.
As shown in Fig. 9 A, tethered N-HA–GW182 reduces 
mRNA levels threefold relative to that measured in cells ex-
pressing the N-HA peptide alone. Depleting HPat did not sig-
nificantly restore reporter mRNA levels (unpublished data). 
This result was expected because we previously showed that at 
least two decapping activators must be codepleted in S2 cells to 
inhibit decapping (Eulalio et al., 2007c).
We then tested whether we could inhibit decapping of the 
F-Luc–5BoxB reporter in cells depleted of HPat plus EDC4, 
DCP1, or Me31B and whether decapping could be restored by 
expressing a dsRNA-resistant form of HPat. To our surprise, 
although  all  combinations  inhibited  decapping,  the  dsRNA- 
resistant form of HPat restored decapping only in cells co-
depleted of HPat and Me31B (Fig. 9 B, lane 4 vs. lane 2). These 
observations indicate that, in this context and/or for this reporter, 
the HPat–Me31B interaction is dispensable for decapping.   
HPat interacts with components of the 
CCR4–NOT deadenylase complex
The finding that HPat triggers deadenylation followed by de-
capping of bound mRNA suggests that HPat interacts with com-
ponents of the deadenylase complex. Accordingly, we observed 
Figure 6.  The proline-rich region is required for HPat accumulation in   
P bodies. (A–F) Confocal fluorescent micrographs of fixed S2 cells ex-
pressing GFP-tagged fusions of full-length HPat or the protein fragments 
indicated on the left. Cells were stained with affinity-purified anti-Tral anti-
bodies. The merged images show the GFP signal in green and the Tral sig-
nal in red. The fraction of cells exhibiting a staining identical to that shown 
in the representative panel was determined by scoring at least 100 cells 
per transfection in three independent transfections performed per protein. 
Mean values ± standard deviations are shown. N-ter, N-terminal; P-rich, 
proline-rich. Bar, 5 µm.297 HPat links deadenylation and decapping • Haas et al.
by HPat mutants lacking Pat-C alone or in combination with the 
Mid domain, indicating that Pat-C is also required for decapping   
in vivo (Fig. 9, B [lanes 12 and 14] and C). Moreover, deleting 
the proline-rich region or the Mid domain also impaired decap-
ping (Fig. 9, B [lanes 8 and 10] and C). Finally, expressing the 
proline-rich region alone was not sufficient to restore decapping 
(Fig. 9, B [lane 16] and C). All proteins were expressed at   
comparable levels and had no dominant-negative effects when 
expressed in control cells (Fig. 9, A and E). Thus, with the   
We next tested whether HPat mutants could restore reporter 
mRNA degradation in the background of the double Me31B–HPat 
knockdown. Here, the HPat mutant lacking the Me31B-binding 
sequence restored mRNA degradation (Fig. 9 B, lane 6), which 
is consistent with a study in S. cerevisiae showing that deleting 
the N-terminal sequence of Pat1 only modestly affects decapping 
(Pilkington and Parker, 2008).
Unlike results obtained in yeast (Pilkington and Parker, 
2008), in our experiments, mRNA degradation was not restored 
Figure  7.  HPat  triggers  deadenylation  and 
decapping  of  bound  mRNAs.  (A–F)  Control 
S2  cells  (treated  with  GFP  dsRNA)  or  cells 
codepleted  of  DCP1  and  EDC4  were  trans-
fected with a mixture of three plasmids, one 
expressing the F-Luc–5BoxB reporter, another 
expressing  R-Luc,  and  a  third  expressing   
N-HA–AGO1-F2V2  (negative  control)  or   
N-HA fusions of wild-type HPat or fragments, 
as indicated. F-Luc activity and mRNA levels 
were normalized to those of the Renilla and 
set to 100 in cells expressing N-HA–AGO1-
F2V2.  Mean  values  ±  standard  deviations 
from  three  independent  experiments  are 
shown. B and E show Northern blot analysis of   
representative RNA samples shown in A and D,   
respectively.  (C)  Full-length  HPat  and  frag-
ments were expressed at comparable levels. 
(F) RNA samples shown in E (lanes 1–3) were 
treated with RNase H in the absence or pres-
ence of oligo (dT) and analyzed by Northern 
blot. rp49 mRNA served as a positive control 
for the RNase H treatment. (G) Western blot 
analysis of control and DCP1–EDC4-depleted 
cell lysates. -Tubulin served as a loading con-
trol.  KD,  knockdown.  (C  and  G)  Molecular 
mass is indicated in kilodaltons. (H) Tethering 
assay in cells expressing a dominant-negative 
mutant of DCP2 (E361Q). In lanes 1 and 2, 
samples  isolated  from  cells  expressing  poly- 
and unadenylated F-Luc–5BoxB mRNA served 
as size markers. (I) S2 cells were transfected 
as described in A. 3 d after transfection, cells 
were  treated  with  5  µg/ml  actinomycin  D   
(ActD)  and  harvested  at  the  indicated  time 
points. The dashed line indicates the position 
of the deadenylated decay intermediate. N-ter, 
N-terminal; P-rich, proline-rich.JCB • VOLUME 189 • NUMBER 2 • 2010   298
HPat, previous studies showing that wild-type Pat1 coimmuno-
precipitates a variety of yeast mRNAs (Tharun et al., 2000;   
Tharun  and  Parker,  2001). We  used  real-time  quantitative   
RT-PCR (RT-qPCR) to analyze the levels of an F-Luc mRNA 
reporter coimmunoprecipitating with HPat and observed that 
HA-HPat  coimmunoprecipitated  the  F-Luc  reporter  10-fold 
more efficiently than did HA-GST, which served as a back-
ground control for the IPs (Fig. 10 A). Furthermore, an HPat 
mutant lacking Pat-C was partially impaired in the association 
with the reporter mRNA, whereas deleting the Mid domain 
abolished association with the F-Luc mRNA (Fig. 10 A). All 
proteins were present in the immunoprecipitates at compara-
ble levels (Fig. 10 B). Thus, the Mid domain, which interacts 
with the LSm1–7 ring, CCR4, and DCP2, is required for HPat   
recruitment to mRNAs. This activity is likely stimulated by the 
contribution of Pat-C.
In  yeast,  Pat1  has  been  reported  to  associate  with   
mRNAs via LSm1-dependent and -independent mechanisms 
and to exhibit RNA-binding activity (Tharun and Parker, 2001; 
Pilkington and Parker, 2008). Accordingly, we observed that 
HPat association with the F-Luc reporter was not affected in 
cells depleted of LSm1 (Fig. 10, A and B). These results sug-
gest  that  HPat  could  be  recruited  to  mRNA  targets  via  a   
redundant mechanism, including the interaction with the dead-
enylase complex, the interaction with the LSm1–7 ring, or direct 
RNA binding.
Discussion
Decapping of eukaryotic mRNAs depends on prior deadenyl-
ation, which ensures that functional, polyadenylated mRNAs 
are not decapped prematurely. However, little is known re-
garding the mechanisms that promote decapping of deadenyl-
ated mRNAs in vivo. In this study, we show that the protein 
HPat coimmunoprecipitates with decapping factors, including 
DCP2, Me31B, and the LSm1–7 ring as well as components of 
the CCR4–NOT deadenylase complex. These findings suggest 
that HPat acts as a bridging factor between the deadenylation 
and decapping machineries. Furthermore, the HPat proline-rich 
region is necessary and sufficient to trigger deadenylation and 
decapping of bound mRNAs. However, in addition to the pro-
line-rich region, both the Mid domain and Pat-C are required 
to  restore  decapping  in  cells  depleted  of  endogenous  HPat. 
Finally, we show that the Mid domain and Pat-C are required 
for HPat recruitment to mRNAs. Therefore, our work suggests 
a model whereby HPat associates with mRNAs undergoing 
deadenylation via interactions with the deadenylase complex or 
the LSm1–7 ring; subsequently, HPat recruits decapping fac-
tors, thereby committing deadenylated mRNAs to degradation 
through the 5 to 3 mRNA decay pathway.
HPat interacts with decapping activators 
and the CCR4–NOT deadenylase complex
In this study, we show that in D. melanogaster cells, HPat co-
immunoprecipitates Me31B, DCP2, the LSm1–7 ring, and com-
ponents of the CCR4–NOT deadenylase complex (Fig. 10 C). 
We mapped the domains on HPat that mediate these interactions 
exception of the N-terminal sequence, all domains of HPat   
contribute to decapping in vivo.
HPat recruitment to mRNAs is mediated 
by the Mid domain and Pat-C
The  Mid  domain  and  Pat-C  were  not  required  for  HPat  to 
promote mRNA degradation in tethering assays but were re-
quired for decapping in complementation assays, so we spec-
ulate that these domains contribute to target mRNA binding. 
To investigate this possibility, we confirmed and extended, for 
Figure 8.  HPat interacts with components of the CCR4–NOT complex. 
(A–C) Interaction between HA-HPat wild type or mutants and GFP-tagged 
components of the CCR4–NOT complex. In lanes 13–18 of A and B, cell 
lysates were treated with RNase A before IP. F-Luc–GFP (A) or HA-GST   
(B and C) served as negative controls. The asterisk indicates cross-reactivity 
of the secondary antibody with the immunoglobin heavy chain. Molecular 
mass is indicated in kilodaltons. N-ter, N-terminal; P-rich, proline-rich.299 HPat links deadenylation and decapping • Haas et al.
and showed that the Mid domain is required for HPat to interact 
with CCR4 and the LSm1–7 ring. Similarly, in S. cerevisiae, the 
corresponding region of Pat1 confers binding to the LSm1–7 
ring (Pilkington and Parker, 2008). Moreover, the Mid domain 
cooperates  with  Pat-C  to  mediate  DCP2  binding,  suggest-
ing that DCP2 binds HPat independently of the LSm1–7 ring.   
Future experiments will unravel whether HPat binds decapping 
and deadenylation factors simultaneously or consecutively and 
whether these interactions are direct.
We also show that a conserved N-terminal sequence 
of HPat interacts with the C-terminal RecA-like domain of 
Me31B. Surprisingly, this conserved sequence is dispensable 
for HPat activity in complementation assays, suggesting that 
mRNAs targeted for GW182-dependent degradation are effi-
ciently decapped even when HPat and Me31B do not interact 
directly. However, the HPat–Me31B interaction may play a role 
in decapping mRNAs degraded by pathways distinct from the 
microRNA pathway.
An important observation is that HPat also interacted with 
components of the CCR4–NOT deadenylase complex. Because 
HPat is not required for deadenylation per se (Eulalio et al., 
2007c; this study), an interaction with the CCR4–NOT complex 
most likely plays a role in recruiting HPat to mRNAs undergo-
ing deadenylation, providing a mechanism to couple decapping 
to the removal of the mRNA poly(A) tail.
Me31B is part of at least three distinct 
protein complexes
Previously, we showed that Me31B interacts with EDC3 and 
Tral to form distinct protein complexes (Tritschler et al., 2009). 
This study shows that a third complex exists, consisting mini-
mally of Me31B, HPat, and the LSm1–7 ring. The interaction 
between Me31B and HPat is also detected in yeast (Coller et al., 
2001; Fischer and Weis, 2002); however, our study revealed that 
EDC3, Tral, and HPat compete for binding to Me31B. Thus, 
Me31B establishes mutually exclusive interactions with EDC3, 
Tral, and HPat. The ability of Me31B and orthologues to estab-
lish mutually exclusive interactions with multiple partners   
provides a mechanistic explanation for the myriad functions 
performed by this protein and further supports the idea that 
Me31B and its orthologues act as remodeling subunits in di-
verse protein complexes (Tritschler et al., 2009). The role of 
these complexes in posttranscriptional mRNA regulation (e.g., 
decapping or translational repression) is specified by the addi-
tional components.
The proline-rich region is required for  
P-body assembly and mRNA decapping
In this study, we show that the proline-rich region of HPat   
promotes  deadenylation  and  decapping  of  bound  RNAs  and   
is required for P-body localization, indicating that this region 
Figure 9.  Complementation assay. (A–E) Control S2 cells (treated with 
GFP dsRNA) or cells codepleted of HPat and Me31B were cotransfected 
with a mixture of three plasmids, one expressing the F-Luc–5BoxB reporter, 
another expressing N-HA–GW182 or the N-HA peptide, and a third 
expressing R-Luc. Plasmids (5 ng) expressing HA-MBP, wild-type HA-HPat,   
or  fragments  (lacking  the  N  tag)  were  included  in  the  transfection 
mixtures, as indicated. RNA samples were analyzed by Northern blot.   
(C) F-Luc activity and mRNA levels were normalized to that of the R-Luc. 
For each condition, the normalized values of F-Luc activity and mRNA 
levels were set to 100 in control cells expressing the N-HA peptide and   
HA-MBP. Mean values ± standard deviations from three independent ex-
periments are shown. Dashed lines indicate F-Luc–5BoxB mRNA levels in 
cells expressing MBP and GW182. (D) Western blot analysis of control and 
HPat–Me31B-depleted cell lysates. -Tubulin served as a loading control. 
(E) Full-length HPat and fragments were expressed at comparable levels.   
(D and E) Molecular mass is indicated in kilodaltons. KD, knockdown;   
N-ter, N-terminal; P-rich, proline-rich.
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interacts with additional components of the mRNA decay pathway. 
However, in IP assays, the proline-rich region was dispensable 
for  HPat  interaction  with  decapping  factors  or  deadenylase 
complex components, suggesting that the binding partners of 
this region remain to be identified.
How can a proline-rich region mediate such diverse ac-
tivities? Proline residues could play a structural role by keep-
ing this region in an extended conformation, rendering short 
sequence motifs accessible for interaction with protein part-
ners. In addition, proline-rich regions can also provide multi-
ple, nonspecific binding sites for protein–protein interactions, 
thereby  contributing  to  the  assembly  of  multiprotein  com-
plexes (Williamson, 1994).
P-body components often contain low-complexity Q/N-
rich regions proposed to facilitate P-body formation via self-
  association or association with Q/N-rich domains on other 
proteins (Decker et al., 2007; Mazzoni et al., 2007; Reijns et al., 
2008). These regions are often rich in proline in addition to or 
instead of glutamine. The region of D. melanogaster HPat re-
quired for P-body localization is rich in proline and glutamine; 
however, the length and composition of this region varies among 
Pat1  orthologues  from  different  species,  suggesting  that  the 
physical interactions between decapping activators that are crit-
ical for P-body localization may not be conserved. This view is 
supported by evidence from S. cerevisiae in which Pat-C but not 
the proline-rich region is required for Pat1 to accumulate in   
P bodies (Pilkington and Parker, 2008).
The Mid domain is required for HPat 
binding to mRNAs
In addition to the proline-rich region, we show that the Mid 
domain and Pat-C are required to restore decapping in cells 
depleted  of  endogenous  HPat.  However,  the  Mid  domain   
and Pat-C are dispensable for mRNA degradation when HPat 
is artificially tethered to an mRNA. One possible explanation 
for this difference is that the reporters used in these assays 
are decapped through distinct mechanisms. An alternative but 
not mutually exclusive explanation is that the Mid domain   
and Pat-C play a role in target binding and therefore are no 
longer required once HPat is tethered to an mRNA. Consis-
tent with this second possibility, we show that the Mid do-
main is essential for HPat to associate with mRNAs. The Mid   
domain may interact with mRNAs indirectly, via the LSm1–7 
ring, as shown in yeast (Tharun and Parker, 2001; Chowdhury   
and Tharun, 2008, 2009). However, our results indicate that   
HPat can associate with mRNAs in LSm1-depleted cells, sug-
gesting that HPat binds RNA either directly or through other   
interacting  partners  (e.g.,  the  CCR4–NOT  complex).  In 
agreement with this, in S. cerevisiae, both the Mid domain 
and  Pat-C  exhibit  RNA-binding  activity  (Pilkington  and   
Parker, 2008).
What role might the Pat-C domain play in decapping? In 
S. cerevisiae, it exhibits RNA-binding activity. Accordingly, in 
D. melanogaster S2 cells, this domain contributes to target 
mRNA binding. However, the absolute requirement for this   
domain in complementation assays suggests that it may have 
additional functions in mRNA decapping.
Figure 10.  The Mid domain is required for HPat recruitment to mRNA tar-
gets. (A) Control or LSm1-depleted S2 cells were transfected with a mixture 
of three plasmids, one expressing an F-Luc reporter, another expressing 
HA-GST, wild-type HA-HPat, or mutants, and a third plasmid expressing   
R-Luc. Cell lysates were immunoprecipitated using an anti-HA antibody. The 
levels of the F-Luc reporter in the immunoprecipitates (IP) were analyzed   
by RT-qPCR and normalized to the corresponding input sample. Mean   
values ± standard deviations from four independent experiments are shown.   
(B) The efficacy of the IPs was examined by Western blotting. Molecular 
mass is indicated in kilodaltons. (C) Schematic model summarizing the pro-
tein interactions described in this study. KD, knockdown; N-ter, N-terminal; 
P-rich, proline-rich.301 HPat links deadenylation and decapping • Haas et al.
0.1 µg reporter plasmid (F-Luc–5BoxB or F-Luc), 0.4 µg pAc5.1–R-Luc as 
transfection control, and 0.025 µg of plasmids expressing N-HA–protein 
fusions. For the complementation assay, cells were depleted on days 0 and 
4, transfected on day 6, and collected on day 9. The transfection mixtures 
contained 0.1 µg reporter plasmid (F-Luc–5BoxB), 0.4 µg pAc5.1–R-Luc as 
transfection control, and 0.1 µg of plasmids expressing the N-HA peptide 
or N-HA–GW182. When indicated, 0.005 µg of plasmids expressing 
wild-type HPat or HPat fragments was cotransfected. HA–maltose-binding 
protein (MBP) served as a negative control. In all experiments, cells were 
collected 3 d after transfection. F-Luc and R-Luc activities were measured 
using the Dual-Luciferase reporter assay system (Promega). Northern blot-
ting was performed as described previously (Behm-Ansmant et al., 2006). 
RNase H (USB) digestion using a (dT)15 oligonucleotide was performed ac-
cording to the manufacturer’s instructions.
Reverse transcription and RT-qPCR
The interaction of HPat with mRNAs was tested as described by Zekri et al. 
(2009). In these experiments, the transfection mixtures contained 0.3 µg of 
an F-Luc reporter plasmid, 0.2 µg of the Renilla transfection control, and 
0.5 µg of plasmid expressing full-length HPat or fragments or HA-GST.   
S2 cells (10–12 × 10
6 cells) were collected 3 d after transfection, washed 
with PBS, and lysed in 0.5 ml of NET buffer (50 mM Tris, pH 7.4, 150 mM 
NaCl, 1 mM EDTA, and 0.1% NP-40) supplemented with protease inhibi-
tors. Cells were lysed by three 30-s sonications, followed by a 15-min incu-
bation on ice. Cells were spun at 16,000 g for 15 min at 4°C. Anti-HA 
antibodies were added to the cleared lysates (2.5 µl/2 × 10
6 cells). After 
1 h at 4°C, aliquots (1/10) of the cleared lysates (input) were kept aside 
for both RNA extraction and Western blotting analysis, and 20 µl of pro-
tein G–agarose was added to the remaining lysate. Before addition to the 
lysates, protein G–agarose beads were preincubated with 0.5 mg of yeast 
RNA and 30 µg BSA for 1 h at 4°C. Lysates were rotated with protein G–
agarose beads for 1 h at 4°C. Beads were washed four times with NET 
buffer and once with NET buffer and eluted with 60 µl of 2× SDS-PAGE 
protein sample buffer. 40 µl of the eluate was used for RNA analysis. RNA 
was prepared from input and immunoprecipitates using TRIZOL-LS reagent 
(Invitrogen)  according  to  the  manufacturer’s  protocol.  DNase  treatment 
was performed using the TURBO DNA-free kit (Applied Biosystems) for   
30 min at 37°C. RNAs were detected via cDNA synthesis and real-time quan-
titative PCR. cDNAs were synthesized with M-MuLV reverse transcription 
(Fermentas) and the F-Luc reporter–specific primer 5-TGTTTACATAACCG-
GACATAATCA-3, according to the manufacturer’s protocols. Quantitative 
PCR analysis was performed using gene-specific primer pairs (as indicated 
below) and SYBR green PCR master mix (Applied Biosystems). Each sam-
ple was analyzed in triplicate. mRNA levels in the immunoprecipitates 
were normalized to the respective input levels. Primer sequences for F-Luc 
reporter are 5-GGCCGAAGACGCCAAAAACATAAAG-3 (forward) and 
5-AATAACGCGCCCAACACCGGCA-3 (reverse).
Online supplemental material
Fig. S1 shows that HPat interacts with LSm1 and DCP2 in an RNA-independent   
manner. Fig. S2 shows that HPat and Tral interact with Me31B in a mutu-
ally exclusive manner. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200910141/DC1.
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A role for HPat in mediating the 
deadenylation dependence of decapping
Our findings suggest that in vivo HPat facilitates the deadenyl-
ation dependence of decapping. Several lines of evidence support 
this assertion. First, HPat may be preferentially recruited to deade-
nylated mRNAs because it associates with the LSm1–7 ring, a pro-
tein complex which binds oligoadenylated mRNAs preferentially 
(Tharun and Parker, 2001; Chowdhury and Tharun, 2008, 2009). In 
addition, we found that components of the deadenylase complex 
interact with HPat, suggesting that HPat is recruited to mRNAs ac-
tively undergoing deadenylation. Once recruited, the association 
between HPat and decapping factors will promote the assembly of 
decapping complexes in cis, committing deadenylated mRNAs to 
degradation via the 5 to 3 mRNA decay pathway.
Materials and methods
DNA constructs
Luciferase reporters and plasmids for the expression of GFP- or N-HA–
tagged  cDNAs  encoding  full-length  AGO1-F2V2,  DCP1,  DCP2,  EDC3, 
EDC4, GW182, LSm1, LSm3, LSm7, Me31B, and Tral were described previ-
ously (Eulalio et al., 2007b; Tritschler et al., 2007, 2008, 2009). A plasmid 
for the expression of HA-XRN1 was obtained by inserting the XRN1 ORF into 
the Not1 and Xba1 sites of pAc5.1–N-HA vector. A plasmid for the expres-
sion of DCP2-V5 was obtained by inserting the DCP2 ORF into the EcoRV 
and Xho1 sites of pAc5.1A, in frame with the V5 epitope. Plasmids for the 
expression of HA- or GFP-tagged HPat were obtained by inserting the HPat 
ORF into the EcoRV and Not1 sites of pAc5.1–N-HA and pAc5.1-EGFP 
vectors.  HPat  fragments  were  cloned  into  the  pAc5.1–N-HA  and 
pAc5.1-EGFP vectors. For the complementation assay shown in Fig. 9, the 
N tag was deleted, and cDNAs were made resistant to HPat dsRNA, which 
targets mRNA sequences encoding aa 743–968 of HPat. Plasmids for the 
expression of deadenylase complex components were obtained by inserting 
the corresponding cDNAs in the pAc5.1–N-EGFP vector using the restriction 
sites EcoRV–Not1 (POP2, which is related to CAF1), EcoR1–Not1 (CCR4), 
HindIII–XbaI (NOT2), HindIII–Not1 (NOT3/5), and XhoI–BstBI (NOT4).
Co-IP assays, Western blotting, and fluorescence microscopy
Transfections were performed in 6-well dishes using Effectene transfection re-
agent (QIAGEN). Protein co-IPs, Western blotting, and immunofluorescence 
were performed as described previously (Tritschler et al., 2007, 2008, 2009). 
For co-IPs, cells were collected 3 d after transfection, washed with PBS, and 
lysed for 15 min on ice in NET buffer (50 mM Tris, pH 7.4, 150 mM NaCl,   
1 mM EDTA, and 0.1% Triton X-100) supplemented with protease inhibitors. 
Cells were spun at 16,000 g for 15 min at 4°C. Anti-HA (Covance) or anti-
GFP antibodies were added to the supernatants (2.5 µl/2 × 10
6 cells). After   
1 h at 4°C, 25 µl of protein G–agarose (Roche) was added, and the mixtures 
were rotated for 1 h at 4°C. Beads were washed three times with NET buffer 
and once with NET buffer without Triton X-100. Bound proteins were eluted 
with sample buffer. Proteins were separated by SDS-PAGE and transferred to 
nitrocellulose membranes. Membranes were blocked in PBS containing 5% 
fat-free milk powder and 0.3% Tween 20. Western blotting was performed 
with polyclonal anti-HA antibodies (1:1,000; Sigma-Aldrich) or anti-GFP anti-
bodies (1:2,000), using the CDP-Star chemiluminescent immunoblot system 
(Western-Star kit; Tropix), as recommended by the manufacturer.
For immunofluorescence, S2 cells were allowed 15 min to adhere 
to poly-d-lysine–coated coverslips and fixed with 2% paraformaldehyde for   
10 min. Cells were then permeabilized with 0.1% Triton X-100 in PBS 
(10 min) and stained with an affinity-purified anti-Tral antibody diluted 1:250 
in PBS containing 1% BSA (1 h). Alexa Fluor 594–labeled goat anti–mouse 
antibody (Invitrogen) was used at a dilution of 1:1,000. Cells were mounted 
using Fluoromount-G (SouthernBiotech). Images were acquired at room tem-
perature using a confocal microscope (TCS SP2; Leica) fitted with a Plan-
Apochromat 100× NA 1.40 oil immersion objective and a series of three 
photomultipliers (Hamamatsu Photonics) controlled with the Leica confocal 
software (version 2.61). Images were prepared using Photoshop (Adobe).
Tethering and complementation assays
RNA interference was performed as described previously (Eulalio et al., 
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